Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 39Colonic Neoplasms 14Colorectal Neoplasms 13Neoplasms 12Rectal Neoplasms 11Prostatic Neoplasms 11Carcinoma, Non-Small-Cell Lung 10Uterine Cervical Neoplasms 8Obesity 8Motor Activity 8Lung Neoplasms 8Endometrial Neoplasms 8Tobacco Use Disorder 6Small Cell Lung Carcinoma 6Overweight 6Depression 6Pancreatic Neoplasms 5Ovarian Neoplasms 5Leukemia, Myeloid, Acute 5Fatigue 5Breast Carcinoma In Situ 5Anxiety Disorders 5Urinary Bladder Neoplasms 4Sexuality 4Sexual Dysfunction, Physiological 4Leukemia 4Head and Neck Neoplasms 4Carcinoma, Renal Cell 4Carcinoma, Intraductal, Noninfiltrating 4Body Weight Changes 4

Interventions

Venlafaxine Hydrochloride 1Specimen Handling 1Selective Serotonin Reuptake Inhibitors 1Psilocybin 1Interviews as Topic 1Dignity Therapy 1Counseling 1Antidepressive Agents, Tricyclic 1Antidepressive Agents 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Depressive Disorder × Counseling × Clear all
NCT07216404 2026-05-14

Psilocybin-Assisted Therapy for the Treatment of Major Depressive Disorder in Patients With Non-Small Cell Lung Cancer

Ohio State University Comprehensive Cancer Center

Phase 2 Recruiting
10 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Depressive Disorder

Data powered by HemOnc (CC BY 4.0) Colophon âš¡